Startups
ten23 health is the human-centric and sustainable strategic partner of choice for the pharmaceutical industry and biotech start-ups for the development, manufacture, and testing of tomorrow’s medicines. We support our clients in developing differentiated, stable, usable, and safe injectable treatments for patients. More about us: www.ten23.health
Overview
Location
Switzerland, Basel-City, Basel
Employees
11-50
Founded date
2021
Mentions in press and media 10
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 19, 2026 | Swiss biotechs display their innovations at BIO 2026 in San Diego | The BIO International Convention attracts over 1,600 exhibitors and 21,000 attendees who network intensively over 4 days, discover new opportunities and promising partnerships. The attendees benefit from a broad spectrum of life sciences a... |
| Oct 31, 2025 | More than 20 Swiss biotech companies to exhibit at Bio Europe | Bio-Europe, the leading partnering conference for the global biotechnology industry, is held annually to connect biotech, pharma, investors, and service providers through one-to-one meetings, presentations, and panels. It serves as a leadi... |
| May 31, 2024 | Swiss life science startups headed for San Diego | The BIO International Convention 2024, taking place in San Diego from 3 to 6 June, is the largest global biotechnology event with over 20,000 industry leaders from around the world attending. The target group includes representatives from ... |
| Jun 5, 2023 | A significant number of Swiss biotechs exhibit in Boston | |
| May 23, 2022 | Swiss Biotechs display their innovations at BIO 2022 International Convention | |
| Mar 28, 2022 | Jazz plots massive growth for UK cannabinoid operations | One year after Jazz Pharmaceuticals acquired GW Pharma and its cannabinoid drug Epidiolex for epilepsy, the company is pumping $100 million into a new manufacturing facility 45 miles from London and the Kent Science Park in Sittingbourne. T... |
| Mar 28, 2022 | In quick turn, ten23 already looking to expand Visp fill-finish site | Last October, ten23 health acquired a Visp, Switzerland, site from swissfillon, a local pharma known for its fill-finish operations. On Monday, the CDMO announced that it will expand the Visp manufacturing site by adding... |
| Oct 25, 2021 | Ten23 health acquires first company shortly after launch | |
| Sep 1, 2021 | New pharma service provider with a solid base |
Reviews 0
FAQ about ten23
When was ten23 founded?
ten23 was founded in 2021.
What has the press written about ten23?
Parsers VC has collected 10 articles mentioning ten23, among them “Swiss biotechs display their innovations at BIO 2026 in San Diego” (Jun 19, 2026) and “More than 20 Swiss biotech companies to exhibit at Bio Europe” (Oct 31, 2025).
Is ten23 still active?
Yes, ten23 is active; its latest activity on Parsers VC dates from Jul 2, 2026.